Gain an in-depth look at pain, explore the latest science on rheumatoid arthritis, and learn more on multiparametric MRI and prostate cancer. Read More

Behavioral science techniques can help facilitate return to work after a temporary disability. RGA recently partnered with the Group Assurance and Behavioral Economics teams of Old Mutual, South Africa, to conduct a trial on the topic. Explore our findings with RGA's Be... Read More

Traditional Chinese medicine (TCM) has become more widely used as part of the frontline treatment for symptoms associated with COVID-19.

RGA's Dr. Si Ning Zhao provides an overview of research dedicated to understanding TCM's role and use... Read More

Embedded insurance is proving to be a powerful way to reach new audiences and to bridge the protection gap. RGA's Diana Bosworth and Matt Berkley examine the current landscape and explain why insurers should closely follow this ...

Read More

The latest novel challenge to establishing a client’s financial insurability has arrived: determining the value of digital assets, including cryptocurrency.

In this article, RGA's Carolyn Pritchard highlights why it's important for underwriters t... Read More

RGA Middle East's Ashley Moheeput reviews how health insurers can use behavioral economics to create positive long-term health outcomes for their customers. The article first appeared in the March 2022 issue of

Read More

Curious about RGA's medical insights?   Conta...

Read More

Curious about RGA's medical insights?  Contact us&...

Read More

The alternative distribution landscape is evolving rapidly, and RGA's Othmane Akesbi argues that insurers can only realize its full potential if they are aware of the breadth of alternative distribution channels available and understand the range of approaches they can ... Read More

As the world enters year three of the COVID-19 pandemic, mortality and morbidity has changed substantially and for the better since the virus’s early days. Successful options for treatment have also been increasing, but at this point they are still few in number. RGA...

Read More

Designing effective applications means making it psychologically easy for applicants to answer questions honestly. In Insurance Thought Leadership ... Read More

Five industry representatives join a lively roundtable discussion on jumbo limit violations in On the Risk. The following experts from TAI and MIB, as well as a direct insurer (Lincoln Financial) and a reinsurer (RGA), explore MIB Jumbo Service, a possible s...

Read More

Curious about RGA's medical insights?  Contact us to learn m...

Read More

Are we at a turning point in the treatment of many genetic and rare diseases? RGA's Hilary Henly explores the ability to target messenger ribonucleic acid (mRNA) using antisense oligonucleotides (ASOs) in On the Risk, the Journal of the Academy of Life Under...

Read More

RGA's Dr. Maryam B. Shapland, Vice President and Medical Director, U.S. Mortality Markets, explores reactive thrombocytosis, a condition associated with higher mortality in acutely ill patients, in Reflections and also in Read More

The survey draws on responses from 124 medical directors representing 84 companies across multiple markets. It reveals how a global public health crisis and intense competitive pressure are reshaping the insurance medical director role. Read More

RGA's Dr. Ola Oyekan, Kate Lyons, and Emmanuel Djengue mark International Women’s Day by discussing the ways access to insurance not only empowers women but lifts entire communities. Women represent an underserved group, as well as an untapped commercial oppor... Read More

Insurers facing outdated technology, legacy processes, and the industry-wide retirement of experienced underwriters are taking a thorough look at how underwriting works within their businesses. RGA's Dave Rengachary offers a new vision for how RGA can help insurers t...

Read More

Explore RGActual, a new magazine covering innovation, experience, and development for insurance professionals. In this issue, learn about the latest trends, projects, and product innovations from around the world influencing our industry.

Read More

The rapid development of liquid biopsy technology, along with its potential for multiple clinical applications, has garnered significant excitement. RGA explores the challenges and concerns, as well as the opportunities ahead. 

Read More